Jefferies Starts Liquidia Technologies (LQDA) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Needham & Company Starts Liquidia Technologies (LQDA) at Buy
August 20, 2018 6:57 AM EDTNeedham & Company analyst Serge Belanger initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Buy rating and a price target of $30.00.
Belanger commented, "We initiate coverage of Liquidia Technologies (LQDA), a late-stage biopharma developing LIQ861, a differentiated inhaled PAH treatment based on its... More
Cowen Starts Liquidia Technologies (LQDA) at Outperform
August 20, 2018 5:40 AM EDTCowen analyst Ken Cacciatore initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Outperform rating and a price target of $40.00.
The analyst comments "The lead asset is LIQ861 for PAH, an inhaled reformulation of a known active molecule, treprostinil, that is more optimally... More



